Board MeetingAug 5, 2026, 07:04 AM
Fennec Pharmaceuticals Q2 2026 Earnings Call Scheduled for Aug 11
AI Summary
Fennec Pharmaceuticals Inc. announced it will release its second quarter 2026 financial results before the U.S. financial markets open on Tuesday, August 11, 2026. Management will host a conference call and webcast on the same day at 8:30 a.m. Eastern Time to discuss the results. The company is a specialty pharmaceutical firm focused on commercializing PEDMARK® to reduce the risk of platinum-induced ototoxicity in cancer patients.
Key Highlights
- Fennec Pharmaceuticals to release Q2 2026 financial results on August 11, 2026.
- Conference call and webcast scheduled for August 11, 2026, at 8:30 a.m. ET.
- Webcast link: https://edge.media-server.com/mmc/p/tjdvggzn.
- Participant registration link: https://register-conf.media-server.com/register/BI48fe753d5b224919a74621f2198f4c38.
- Replay of the webcast will be available on the company's website for 30 days.
- Fennec Pharmaceuticals focuses on commercializing PEDMARK/PEDMARQSI for ototoxicity.
Price Impact
More from FENC